Takara spins off biotech unit
Tuesday, 02 April, 2002
Japanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
The split, which was completed on Monday (April 1) as the new Japanese fiscal year began, has resulted in the formation of two companies, Takara Shuzo Co Ltd and Takara Biomedical Co Ltd, under a single holding company, Takara Holdings Inc.
Otsu, Japan based Takara Biomedical includes Dragon Genomics, a genome analysis center formed last year in western Japan.
Repurposed drugs show promise in heart muscle regeneration
The FDA-approved medications, when given in combination, target two proteins that regulate the...
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
